EcoR1 Capital LLC 13D and 13G filings for Odonate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-12-10 5:24 pm Sale |
2021-12-10 | 13G | Odonate Therapeutics, Inc. ODTC |
EcoR1 Capital LLC | 0 0.000% |
-0 (Position Closed) |
Filing |
| 2021-11-18 1:03 pm Purchase |
2021-11-17 | 13G | Odonate Therapeutics, Inc. ODTC |
EcoR1 Capital LLC | 0 14.800% |
0 (+69.51%) |
Filing |
| 2021-07-19 5:23 pm Purchase |
2021-07-08 | 13G | Odonate Therapeutics, Inc. ODTC |
EcoR1 Capital LLC | 0 8.700% |
0 (New Position) |
Filing |